Meta-analysis
Mark H. de Jong, MD; Astrid M. Kamperman, PhD; Margreet Oorschot, PhD; et al.
free access
JAMA Psychiatry. 2016;73(7):657-664. doi:10.1001/jamapsychiatry.2016.0501
This systematic review and meta-analysis establishes which interventions (advance statements, community treatment orders, compliance enhancement, or integrated treatment) effectively reduce compulsory admissions in adult psychiatric patients in outpatient settings.
-
Editorial
Joint Decision Making and Reduced Need for Compulsory Psychiatric Admission
Graham Thornicroft, PhD, MSc, MBBS; Claire Henderson, PhD, MSc, MBBS
JAMA Psychiatry
Meta-analysis
Kate Merritt, MSc; Alice Egerton, PhD; Matthew J. Kempton, PhD; et al.
free access
JAMA Psychiatry. 2016;73(7):665-674. doi:10.1001/jamapsychiatry.2016.0442
This meta-analysis evaluates the levels of glutamate, glutamine, or the combined Glx signals determined with proton magnetic resonance spectroscopy in patients at high risk for schizophrenia as well as in those with first-episode psychosis or chronic schizophrenia.
Jorge A. Quiroz, MD, MBA; Paul Tamburri, PharmD; Dennis Deptula, PhD; et al.
free access
JAMA Psychiatry. 2016;73(7):675-684. doi:10.1001/jamapsychiatry.2016.0838
This randomized clinical trial evaluates the safety and efficacy of basimglurant modified-release vs placebo as adjunctive therapy to ongoing antidepressant medication therapy in patients with major depressive disorder who had inadequate response within the current episode.
M. Katherine Shear, MD; Charles F. Reynolds III, MD; Naomi M. Simon, MD, MSc; et al.
free access
JAMA Psychiatry. 2016;73(7):685-694. doi:10.1001/jamapsychiatry.2016.0892
This randomized trial compares the efficacy of targeted complicated grief treatment, citalopram, both, or neither on the outcomes of patients with complicated grief.
Murray B. Stein, MD, MPH; Chia-Yen Chen, ScD; Robert J. Ursano, MD; et al.
free access
JAMA Psychiatry. 2016;73(7):695-704. doi:10.1001/jamapsychiatry.2016.0350
This genome-wide association study assesses genetic loci associated with the lifetime risk for posttraumatic stress disorder in 2 cohorts of US military personnel and veterans.
Arthur Caye; Thiago Botter-Maio Rocha, MD, MSc; Luciana Anselmi, PhD; et al.
free access
JAMA Psychiatry. 2016;73(7):705-712. doi:10.1001/jamapsychiatry.2016.0383
This study investigates whether impaired young adults with attention-deficit/hyperactivity disorder symptoms always have a childhood-onset disorder in a population-based longitudinal study.
-
Editorial
Can Attention-Deficit/Hyperactivity Disorder Onset Occur in Adulthood?
Stephen V. Faraone, PhD; Joseph Biederman, MD
JAMA Psychiatry
Jessica C. Agnew-Blais, ScD; Guilherme V. Polanczyk, MD, PhD; Andrea Danese, MD, PhD; et al.
free access
JAMA Psychiatry. 2016;73(7):713-720. doi:10.1001/jamapsychiatry.2016.0465
This study investigates childhood risk factors and functioning in young adults with persistent, remitted, and late-onset ADHD.
-
Editorial
Can Attention-Deficit/Hyperactivity Disorder Onset Occur in Adulthood?
Stephen V. Faraone, PhD; Joseph Biederman, MD
JAMA Psychiatry
Elaine H. Morrato, DrPH, MPH; Elizabeth J. Campagna, MS; Sarah E. Brewer, MPA; et al.
free access
JAMA Psychiatry. 2016;73(7):721-730. doi:10.1001/jamapsychiatry.2016.0538
This observational study examines the use of glucose and lipid testing in Medicaid patients receiving antipsychotic therapy.
Madeline H. Meier, PhD; Avshalom Caspi, PhD; Magdalena Cerdá, DrPH; et al.
free access
JAMA Psychiatry. 2016;73(7):731-740. doi:10.1001/jamapsychiatry.2016.0637
This 38-year longitudinal study of a representative birth cohort (the Dunedin Multidisciplinary Health and Development Study of New Zealand) tests associations between cannabis use over 20 years and a variety of physical health indexes at early midlife.
Robert J. Ursano, MD; Ronald C. Kessler, PhD; Murray B. Stein, MD, MPH; et al.
free access
JAMA Psychiatry. 2016;73(7):741-749. doi:10.1001/jamapsychiatry.2016.0600
This longitudinal cohort study examines suicide attempt risk factors, methods, and timing among soldiers currently deployed, previously deployed, and never deployed.